DeepMed Research

HAMAD MEDICAL CORPORATION

🇶🇦Qatar

Country: 🇶🇦Qatar

Ownership: -

Established: 1979-01-01

Employees: -

Market Cap: -

Website: https://www.hamad.qa

Clinical Trials

Early Nutritional Intervention in Patients With Autism Spectrum Disorders

Not Applicable

Completed

Conditions: Autism Spectrum Disorders
Stable Clinical Condition in the Last 3 Months

Interventions: Dietary Supplement: Pyridoxine hydrochloride
Other: Tang orange powder

First Posted Date: 2010-10-29

Last Posted Date: 2011-07-19

Lead Sponsor: Hamad Medical Corporation

Target Recruit Count: 40

Registration Number: NCT01230359

Locations: 🇶🇦
Rumailah Hospital, Doha, Qatar

Effect of Taurine on Glycemic Control in Type I and Type II Diabetic Patients

Phase 1

Conditions: it is a Group of Metabolic Diseases in
Which a Person Has High Blood Sugar, Either
Because the Body Does Not Produce Enough Insulin,
or Because Cells do Not Respond to the Insulin That
is Produced.

Interventions: Drug: Taurine

First Posted Date: 2010-10-22

Last Posted Date: 2012-11-09

Lead Sponsor: Hamad Medical Corporation

Target Recruit Count: 20

Registration Number: NCT01226537

Ondansetron Versus Metoclopramide in Treatment of Vomiting in Gastroenteritis

Phase 4

Completed

Conditions: Gastroenteritis

Interventions: Drug: Treatment 2 Ondansetron
Drug: Treatment 1. Metoclopramide

First Posted Date: 2010-07-20

Last Posted Date: 2010-10-26

Lead Sponsor: Hamad Medical Corporation

Target Recruit Count: 170

Registration Number: NCT01165866

Locations: 🇶🇦
Pediatric Emergency Centre, Al-Saad, Doha, Qatar

Dexamethasone in the Treatment of Bronchiolitis in Patients With Either Eczema and or Family History of Asthma

Phase 1

Completed

Conditions: Bronchiolitis

Interventions: Drug: Dexamethasone
Drug: Placebo

First Posted Date: 2010-02-09

Last Posted Date: 2016-08-10

Lead Sponsor: Hamad Medical Corporation

Target Recruit Count: 200

Registration Number: NCT01065272

Locations: 🇶🇦
Hamad Medical Corporation, Pediatric Emergency Center,Alsaad., Doha, Qatar

Nebulized 5% Hypertonic Saline for the Treatment of Bronchiolitis

Phase 4

Completed

Conditions: Bronchiolitis

Interventions: Drug: Treatment 1. (5% Hypertonic saline + Epinephrine)
Drug: Treatment 3. (3% Hypertonic saline + Epinephrine)
Drug: Treatment 2. (Normal saline + Epinephrine)

First Posted Date: 2009-11-19

Last Posted Date: 2009-11-19

Lead Sponsor: Hamad Medical Corporation

Target Recruit Count: 187

Registration Number: NCT01016249

Locations: 🇶🇦
Pediatric Emergency Center, Al-Saad, Doha, Qatar

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy